前网络超连接是阿尔茨海默病的关键:从衰老到痴呆
Léa Chauveau1, Brigitte Landeau1, Sophie Dautricourt1,2
1U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Neuropresage Team; INSERM, University of Caen Normandy; GIP Cyceron, 14000 Caen, France.
Brain : a journal of neurology
|January 15, 2025
概括
前 (AT) 网络中的过度连接与阿尔茨海默病的进展有关. 在老年人中的这一发现可能有助于开发阿尔茨海默病的预后工具和治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 的病理生理学和进展仍然不完全理解,这阻碍了有效的治疗.
- 中间叶网络功能障碍,特别是前 (AT) 和后 (PM) 系统,在AD连续体中表现出改变.
- 了解网络变化及其在AD各个阶段的临床相关性,考虑到生物标志物,进展和年龄,至关重要.
研究的目的:
- 调查AT和PM网络连接的特定年龄和AD相关变化.
- 检查网络连接和AD生物标志物,临床进展和认知功能之间的关系.
- 为了确定AT网络超连接是否与AD病理和进展密切相关.
主要方法:
- 对261名参与者 (19-85岁) 在成年人寿和AD连续性 (认知不受损,MCI,AD痴呆症) 的纵向分析.
- 利用结构性MRI,静止状态fMRI,PET成像 (氨基酸β,葡萄糖代谢) 和多达47个月的认知评估.
- 使用种子分析评估了AT和PM网络连接,并分析了基于年龄的特异性影响和AD相关的变化,使用混合效应模型.
主要成果:
- 正常的衰老与PM连接性降低和微妙的AT连接性变化有关.
- AD的特点是增加了AT连接,独立于全球PM连接变化.
- 在MCI患者中,更高的AT连接与AD生物标志物 (粉样蛋白负担,低代谢,缩),认知缺陷和更快的痴呆进展相关.
结论:
- 独特的连接模式区分了正常的衰老和阿尔茨海默病.
- 过度的AT网络连接与阿尔茨海默病的病理和临床进展密切相关.
- 研究结果支持AT网络的改变作为潜在的预后标志物和阿尔茨海默病的治疗点.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
440
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
440
Dementia
94
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
94
Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
Aging
36
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
36


